retatrutide phase 2 trial obesity nejm 2023 triple agonist new england journal of medicine Triple–Hormone-Receptor Retatrutide for — Triple–Hormone-Receptor Agonist Retatrutide for Obesity
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22


























